PTSD Trial, Recruiting (NCT04426448)

PTSD Trial, Recruiting NCT04426448 Sponsor: University of Botswana Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT04426448 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are able to understand and communicate in either Setswana or English
You have been diagnosed with a serious mental illness (SMI) such as schizophrenia, schizophreniform disorder, schizoaffective disorder, bipolar disorder, or severe depression, based on standard diagnostic guidelines
You have been assessed and meet the criteria for Post-Traumatic Stress Disorder (PTSD), as measured by a standard checklist called the PCL-5

Who may not be able to join:

You are currently receiving talking therapy (psychotherapy) specifically for PTSD
You are currently taking medication specifically prescribed to treat PTSD symptoms
You are not able to understand or give informed consent to participate in the study
You are not able to answer interview questions during the study
You have had thoughts of suicide or have made a suicide attempt in the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Keneilwe Molebatsi, MMED (Psych), University of Botswana

Phone: +26777458378

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04426448

Sponsor: University of Botswana

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: +26777458378

More information: https://clinicaltrials.gov/study/NCT04426448

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are able to understand and communicate in either Setswana or English
You have been diagnosed with a serious mental illness (SMI) such as schizophrenia, schizophreniform disorder, schizoaffective disorder, bipolar disorder, or severe depression, based on standard diagnostic guidelines
You have been assessed and meet the criteria for Post-Traumatic Stress Disorder (PTSD), as measured by a standard checklist called the PCL-5

Who may not be able to join:

You are currently receiving talking therapy (psychotherapy) specifically for PTSD
You are currently taking medication specifically prescribed to treat PTSD symptoms
You are not able to understand or give informed consent to participate in the study
You are not able to answer interview questions during the study
You have had thoughts of suicide or have made a suicide attempt in the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Botswana

Registry

ClinicalTrials.gov

Start date

8 July 2020

Est. completion

30 August 2025

Where this trial is recruiting

Botswana

Primary endpoints

Post Traumatic Checklist-5; eSense EDA skin conductance device; Mini International Neuropsychiatric Interview (MINI) Plus; Consent rates; Adherence rates; knowledge of PTSD scale (KPTSD); Acceptability of Intervention measure (AIM); Feasibility of Intervention Measure (FIM); Patient satisfaction scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov